The differences between pure and mixed invasive micropapillary breast cancer: the epithelial-mesenchymal transition molecules and prognosis

被引:0
|
作者
Oz, Ozden [1 ]
Yuzuguldu, Resmiye Irmak [2 ]
Yazici, Ayse [3 ]
Cavdar, Demet Kocatepe [1 ]
Yilmaz, Cengiz [4 ]
Ozturk, Mucteba [5 ]
Duzel, Hilal [6 ]
Gurel, Duygu [7 ]
机构
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Pathol, Izmir, Turkiye
[2] Mugla Training & Res Hosp, Dept Pathol, Mugla, Turkiye
[3] Izmir Katip Celebi Univ, Training & Res Hosp, Fac Med, Dept Pathol, Izmir, Turkiye
[4] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Med Oncol, Izmir, Turkiye
[5] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Gen Surg, Izmir, Turkiye
[6] Dokuz Eylul Univ, Med Fac, Dept Publ Hlth, Izmir, Turkiye
[7] Dokuz Eylul Univ, Med Fac, Dept Pathol, Izmir, Turkiye
关键词
Pure breast micropapillary carcinoma; Epithelial-mesenchymal transition (EMT); Prognostic parameters; Prognosis; CARCINOMA; PROGRESSION; FEATURES; VARIANT;
D O I
10.1007/s10549-024-07384-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Invasive micropapillary carcinoma (IMPC) of the breast is known for its high metastatic potential, but the definition of pure and mixed IMPC remains unclear. This retrospective cohort study aims to investigate the prognostic significance of the micropapillary component ratio and the expression of critical molecules of epithelial-mesenchymal transition (EMT), including E-cadherin (E-cad), N-cadherin (N-cad), CD44s, and beta-catenin (beta-cat), in distinguishing between pure and mixed IMPCs. Methods We analyzed 100 cases of locally advanced IMPC between 2000 and 2018 and excluded patients who received neoadjuvant chemotherapy. Pure IMPC was defined as having a micropapillary component of over 90%. A comprehensive recording of prognostic parameters was conducted. The IMPC areas were analyzed using the immunohistochemical (IHC) staining method on the microarray set for pure and mixed IMPC patients. Pearson's chi-square, Fisher's exact tests, Kaplan-Meier analysis, and Cox proportional hazards analysis were employed. Results The comparative survival analysis of the entire group, based on overall survival (OS) and disease-free survival (DFS), revealed no significant difference between the pure and mixed groups (P = 0.480, HR = 1.474 [0.502-4.325] and P = 0.390, HR = 1.587 [0.550-4.640], respectively). However, in the pure IMPC group, certain factors were found to be associated with a higher risk of short survival. These factors included skin involvement (P = 0.050), pT3&4 category (P = 0.006), a ratio of intraductal component (> 5%) (P = 0.032), and high-level expression of N-cad (P = 0.020). Notably, none of the risk factors identified for short OS in pure IMPC cases were observed as significant risks in mixed cases and vice versa. Furthermore, N-cad was identified as a poor prognostic marker for OS in pure IMPCs (P = 0.002). Conclusion The selection of a 90% ratio for classifying pure IMPCs revealed significant differences in certain molecular and prognostic parameters between pure and mixed groups. Notably, the involvement of N-cadherin in the epithelial-mesenchymal transition (EMT) process provided crucial insights for predicting OS and DFS while also distinguishing between the two groups. These findings strongly support the notion that the pure IMPC subgroup represents a distinct entity characterized by unique molecular characteristics and behavioral patterns.
引用
收藏
页码:41 / 55
页数:15
相关论文
共 50 条
  • [1] Comprehensive Immunohistochemical Analysis of Epithelial-Mesenchymal Transition Biomarkers in the Invasive Micropapillary Cancer of the Breast
    Oz, Ozden
    Tasli, Funda Alkan
    Yuzuguldu, Resmiye Irmak
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Durak, Merih Guray
    Durusoy, Raika
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2024, 2024
  • [2] Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study
    Magnoni, Francesca
    Bianchi, Beatrice
    Pagan, Eleonora
    Corso, Giovanni
    Sala, Isabella
    Bagnardi, Vincenzo
    Claudia, Sangalli
    Brancaccio, Roberta
    Bottazzoli, Elisa
    Boato, Antony
    Munzone, Elisabetta
    Dellapasqua, Silvia
    Fusco, Nicola
    Viviana, Galimberti
    Veronesi, Paolo
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (02) : 333 - 347
  • [3] Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis
    Kim, Eun Young
    Ahn, Sangjeong
    ANTICANCER RESEARCH, 2023, 43 (05) : 2281 - 2292
  • [4] Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer
    Khadri, Fatima-Zohra
    Issac, Marianne Samir Makboul
    Gaboury, Louis Arthur
    CANCERS, 2021, 13 (20)
  • [5] The prognostic significanc of epithelial-mesenchymal transition in breast cancer
    Fuchs, IB
    Lichtenegger, W
    Buehler, H
    Henrich, W
    Stein, H
    Kleine-Tebbe, A
    Schaller, G
    ANTICANCER RESEARCH, 2002, 22 (6A) : 3415 - 3419
  • [6] Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer
    Masugi, Yohei
    Yamazaki, Ken
    Hibi, Taizo
    Aiura, Koichi
    Kitagawa, Yuko
    Sakamoto, Michiie
    HUMAN PATHOLOGY, 2010, 41 (08) : 1061 - 1068
  • [7] Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer
    Alkatout, Ibrahim
    Wiedermann, Meike
    Bauer, Maret
    Wenners, Antonia
    Jonat, Walter
    Klapper, Wolfram
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 168 - 173
  • [8] Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer
    Kouso, Hidenori
    Yano, Tokujiro
    Maruyama, Riichiroh
    Shikada, Yasunori
    Okamoto, Tatsuro
    Haro, Akira
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    SURGERY TODAY, 2013, 43 (01) : 73 - 80
  • [9] Epithelial-mesenchymal transition inducer Snail1 and invasive potential of intraductal breast cancer
    Szynglarewicz, Bartlomiej
    Kasprzak, Piotr
    Donizy, Piotr
    Biecek, Przemyslaw
    Halon, Agnieszka
    Matkowski, Rafal
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (06) : 696 - 705
  • [10] SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro
    Wang, L.
    Zhang, J.
    Yang, X.
    Chang, Y. W. Y.
    Qi, M.
    Zhou, Z.
    Zhang, J.
    Han, B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) : 301 - 307